Indirect Calorimetry in Patients at Risk of Malnutrition

NCT ID: NCT04500483

Last Updated: 2023-06-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-08-15

Study Completion Date

2025-08-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Burn patients treated in an outpatient clinic and ICU survivors are at risk of malnutrition. There are no clear guidelines determining the energy target in those two populations. The aim of this observation study is to measure the resting energy expenditure of those patients, using indirect calorimetry.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Burns Critical Illness Indirect Calorimetry Resting Energy Expenditure Nutrition Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Burn outpatients

Burn patients treated for minor burns in an outpatient setting

indirect calorimetry

Intervention Type DIAGNOSTIC_TEST

measurement of resting energy expenditure using indirect calorimetry

ICU survivors

Critically ill patients who survived ICU stay and are admitted in a general ward

indirect calorimetry

Intervention Type DIAGNOSTIC_TEST

measurement of resting energy expenditure using indirect calorimetry

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

indirect calorimetry

measurement of resting energy expenditure using indirect calorimetry

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* minor burn treated in an outpatient setting
* ICU survivor, who was discharged from ICU after a stay of at least 7 days

Exclusion Criteria

* oxygen supply
* chest drainage
* not french speaking
* confusion, coma
* cognitive disorder
* patient refusal
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Liege

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Anne-Françoise Rousseau

Head of clinic

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital of Liège

Liège, , Belgium

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Anne-Françoise Rousseau, MD, PhD

Role: CONTACT

+3243667495

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Anne-Françoise Rousseau, PhD

Role: primary

+3243667495

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CaloIF

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.